Conference Coverage ACC 2022 See All Content See past conferences Washington, DC April 02, 2022 April 04, 2022 News Conference News ACC 2022 DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF At least 85% of patients were able to have RAASi therapy optimized without concomitant risk of excess serum potassium. < > METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF Todd Neale April 08, 2022 SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures Todd Neale April 08, 2022 News Conference News ACC 2022 Seasonal, but No Year-round Help for HF With Flu Shots: IVVE Yael L. Maxwell April 03, 2022 News Conference News ACC 2022 PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization L.A. McKeown April 03, 2022 News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022 News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022 News Conference News ACC 2022 Tailored Nutrition Advice at the Grocery Store Works: SuperWIN Caitlin E. Cox April 03, 2022 News News Conference News ACC 2022 POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery Todd Neale April 06, 2022 News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022 News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022 Slides Presentation ACC 2022 Quality Of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery Presenter: Frederik M. Zimmermann April 03, 2022 Presentation ACC 2022 TRANSLATE-TIMI 70 Presenter: Brian Bergmark April 04, 2022 Presentation ACC 2022 Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Presenter: Milind Y Desai April 03, 2022 @TCTMD Follow Us
News Conference News ACC 2022 DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF At least 85% of patients were able to have RAASi therapy optimized without concomitant risk of excess serum potassium.
News Conference News ACC 2022 Seasonal, but No Year-round Help for HF With Flu Shots: IVVE Yael L. Maxwell April 03, 2022
News Conference News ACC 2022 PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization L.A. McKeown April 03, 2022
News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Conference News ACC 2022 Tailored Nutrition Advice at the Grocery Store Works: SuperWIN Caitlin E. Cox April 03, 2022
News Conference News ACC 2022 POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery Todd Neale April 06, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
Presentation ACC 2022 Quality Of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery Presenter: Frederik M. Zimmermann April 03, 2022
Presentation ACC 2022 Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Presenter: Milind Y Desai April 03, 2022